CRU 2025: Neurotrophic keratitis and multidisciplinary approaches to enhance patient outcomes

News
Video

Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.

Jennifer Li, MD, a professor of ophthalmology at UC Davis Eye Center, provides an in-depth overview of neurotrophic keratitis (NK), emphasizing its critical yet often overlooked nature in eye care. NK is a condition characterized by reduced corneal sensation that frequently goes undiagnosed. Li stresses the importance of healthcare providers keeping this condition in mind, especially when patients present with dry eye symptoms. The key to early detection is a simple corneal sensation test, which can be performed using a cotton wisp, comparing sensation between both eyes. The diagnostic approach involves checking corneal sensation in all quadrants, starting with the unaffected eye. Li advises against applying eye drops before testing, as this can interfere with accurate sensation assessment. She recommends testing with a small cotton wisp, not the entire cotton swab, to get precise results. Management of NK is multifaceted and patient-specific. Initial steps include:

  • Lubrication
  • Removing potential irritants
  • Eliminating preservatives from eye drops

Advanced treatment options encompass:

  • Nerve growth factor medications
  • Scleral contact lens fitting
  • Surgical interventions like neuronization

Li emphasizes a collaborative approach, working closely with optometrists and oculoplastic surgeons to provide comprehensive care. Each patient requires a tailored strategy, considering their unique underlying causes and symptoms. The overarching message is early detection and proactive management. By maintaining a high index of suspicion for NK, checking corneal sensation systematically, and adopting a stepwise treatment approach, healthcare providers can significantly improve patient outcomes. Key takeaways include the simplicity of diagnosis, the importance of thorough examination, and the need for personalized, collaborative treatment strategies in managing NK.

Recent Videos
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Alongside Rachelle Lin, OD, MS, FAAO; Nguyễn, MD, MSc, detailed what treatments are currently available for retinal vascular diseases, including neovascular age-related macular degeneration and diabetic retinopathy.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
Mile Brujic, OD, FAAO; Nate Lighthizer, OD, FAAO; Brianna Rhue, OD, FAAO, FSLS; Ben Casella, OD; and Ben Gaddie, OD, FAAO shared their insights from the conference.
Dr. Stephanie Woo discusses the upcoming CRU Eye Symposium
Agatha Sleboda, OD; Arti Shah, OD, FAAO; and Kent J. Nozacki, OD provide the best tips that they give to their patients during natural disasters events in light of the recent Greater Los Angeles wildfires.
© 2025 MJH Life Sciences

All rights reserved.